263 related articles for article (PubMed ID: 28811492)
1. Interferon-alpha treatment rapidly clears Hepatitis E virus infection in humanized mice.
van de Garde MDB; Pas SD; van Oord GW; Gama L; Choi Y; de Man RA; Boonstra A; Vanwolleghem T
Sci Rep; 2017 Aug; 7(1):8267. PubMed ID: 28811492
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection.
van de Garde MD; Pas SD; van der Net G; de Man RA; Osterhaus AD; Haagmans BL; Boonstra A; Vanwolleghem T
J Virol; 2016 May; 90(9):4394-401. PubMed ID: 26889028
[TBL] [Abstract][Full Text] [Related]
3. Immune cell responses are not required to induce substantial hepatitis B virus antigen decline during pegylated interferon-alpha administration.
Allweiss L; Volz T; Lütgehetmann M; Giersch K; Bornscheuer T; Lohse AW; Petersen J; Ma H; Klumpp K; Fletcher SP; Dandri M
J Hepatol; 2014 Mar; 60(3):500-7. PubMed ID: 24398036
[TBL] [Abstract][Full Text] [Related]
4. Antiviral Activities of Different Interferon Types and Subtypes against Hepatitis E Virus Replication.
Todt D; François C; Anggakusuma ; Behrendt P; Engelmann M; Knegendorf L; Vieyres G; Wedemeyer H; Hartmann R; Pietschmann T; Duverlie G; Steinmann E
Antimicrob Agents Chemother; 2016 Apr; 60(4):2132-9. PubMed ID: 26787701
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of NVR 3-778, Alone and In Combination With Pegylated Interferon, vs Entecavir In uPA/SCID Mice With Humanized Livers and HBV Infection.
Klumpp K; Shimada T; Allweiss L; Volz T; Lütgehetmann M; Hartman G; Flores OA; Lam AM; Dandri M
Gastroenterology; 2018 Feb; 154(3):652-662.e8. PubMed ID: 29079518
[TBL] [Abstract][Full Text] [Related]
6. Development of a Novel Site-Specific Pegylated Interferon Beta for Antiviral Therapy of Chronic Hepatitis B Virus.
Tsuge M; Uchida T; Hiraga N; Kan H; Makokha GN; Abe-Chayama H; Miki D; Imamura M; Ochi H; Hayes CN; Shimozono R; Iwamura T; Narumi H; Suzuki T; Kainoh M; Taniguchi T; Chayama K
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28373196
[TBL] [Abstract][Full Text] [Related]
7. The Viral ORF3 Protein Is Required for Hepatitis E Virus Apical Release and Efficient Growth in Polarized Hepatocytes and Humanized Mice.
Sari G; Zhu J; Ambardekar C; Yin X; Boonstra A; Feng Z; Vanwolleghem T
J Virol; 2021 Nov; 95(23):e0058521. PubMed ID: 34523963
[TBL] [Abstract][Full Text] [Related]
8. The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo.
Todt D; Moeller N; Praditya D; Kinast V; Friesland M; Engelmann M; Verhoye L; Sayed IM; Behrendt P; Dao Thi VL; Meuleman P; Steinmann E
Antiviral Res; 2018 Sep; 157():151-158. PubMed ID: 30036559
[TBL] [Abstract][Full Text] [Related]
9. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation.
Allweiss L; Gass S; Giersch K; Groth A; Kah J; Volz T; Rapp G; Schöbel A; Lohse AW; Polywka S; Pischke S; Herker E; Dandri M; Lütgehetmann M
J Hepatol; 2016 May; 64(5):1033-1040. PubMed ID: 26805671
[TBL] [Abstract][Full Text] [Related]
10. Treatment induced clearance of hepatitis E viruses by interferon-lambda in liver-humanized mice.
Sari G; Mulders CE; Zhu J; van Oord GW; Feng Z; Kreeft-Voermans JJC; Boonstra A; Vanwolleghem T
Liver Int; 2021 Dec; 41(12):2866-2873. PubMed ID: 34392598
[TBL] [Abstract][Full Text] [Related]
11. Understanding Hepatitis B Virus Dynamics and the Antiviral Effect of Interferon Alpha Treatment in Humanized Chimeric Mice.
Reinharz V; Ishida Y; Tsuge M; Durso-Cain K; Chung TL; Tateno C; Perelson AS; Uprichard SL; Chayama K; Dahari H
J Virol; 2021 Jun; 95(14):e0049220. PubMed ID: 33910953
[TBL] [Abstract][Full Text] [Related]
12. ISG15 Modulates Type I Interferon Signaling and the Antiviral Response during Hepatitis E Virus Replication.
Sooryanarain H; Rogers AJ; Cao D; Haac MER; Karpe YA; Meng XJ
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724761
[TBL] [Abstract][Full Text] [Related]
13. Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver.
Sayed IM; Verhoye L; Cocquerel L; Abravanel F; Foquet L; Montpellier C; Debing Y; Farhoudi A; Wychowski C; Dubuisson J; Leroux-Roels G; Neyts J; Izopet J; Michiels T; Meuleman P
Gut; 2017 May; 66(5):920-929. PubMed ID: 27006186
[TBL] [Abstract][Full Text] [Related]
14. Robust hepatitis E virus infection and transcriptional response in human hepatocytes.
Todt D; Friesland M; Moeller N; Praditya D; Kinast V; Brüggemann Y; Knegendorf L; Burkard T; Steinmann J; Burm R; Verhoye L; Wahid A; Meister TL; Engelmann M; Pfankuche VM; Puff C; Vondran FWR; Baumgärtner W; Meuleman P; Behrendt P; Steinmann E
Proc Natl Acad Sci U S A; 2020 Jan; 117(3):1731-1741. PubMed ID: 31896581
[TBL] [Abstract][Full Text] [Related]
15. Host Innate Immunity against Hepatitis E Virus and Viral Evasion Mechanisms.
Kang S; Myoung J
J Microbiol Biotechnol; 2017 Oct; 27(10):1727-1735. PubMed ID: 29017236
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis E Virus (HEV) Open Reading Frame 2 Antigen Kinetics in Human-Liver Chimeric Mice and Its Impact on HEV Diagnosis.
Sayed IM; Verhoye L; Montpellier C; Abravanel F; Izopet J; Cocquerel L; Meuleman P
J Infect Dis; 2019 Jul; 220(5):811-819. PubMed ID: 31001628
[TBL] [Abstract][Full Text] [Related]
17. Transcriptome analysis in rhesus macaques infected with hepatitis E virus genotype 1/3 infections and genotype 1 re-infection.
Choi YH; Zhang X; Srinivasamoorthy G; Purdy MA
PLoS One; 2020; 15(9):e0237618. PubMed ID: 32877413
[TBL] [Abstract][Full Text] [Related]
18. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
19. Zinc Salts Block Hepatitis E Virus Replication by Inhibiting the Activity of Viral RNA-Dependent RNA Polymerase.
Kaushik N; Subramani C; Anang S; Muthumohan R; Shalimar ; Nayak B; Ranjith-Kumar CT; Surjit M
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814517
[TBL] [Abstract][Full Text] [Related]
20. Zinc: A Potential Antiviral Against Hepatitis E Virus Infection?
Kaushik N; Anang S; Ganti KP; Surjit M
DNA Cell Biol; 2018 Jul; 37(7):593-599. PubMed ID: 29897788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
